journal
MENU ▼
Read by QxMD icon Read
search

BMC Dermatology

journal
https://read.qxmd.com/read/30704477/a-novel-elastin-gene-frameshift-mutation-in-a-russian-family-with-cutis-laxa-a-case-report
#1
E G Okuneva, A A Kozina, N V Baryshnikova, A Yu Krasnenko, K Yu Tsukanov, O I Klimchuk, E I Surkova, V V Ilinsky
BACKGROUND: Cutis laxa (CL) is a rare connective tissue disorder characterized by loose, redundant, inelastic and wrinkled skin. Patients develop a prematurely aged appearance. Inheritance can be autosomal dominant or autosomal recessive. The X-linked form is now classified in the group of copper transport diseases. Autosomal dominant CL is characterized by wrinkled, redundant and sagging, inelastic skin and in some cases is associated with internal organ involvement. CASE PRESENTATION: We report a familial case of autosomal dominant CL, which includes a 33-year-old woman and her 11-year-old son with dry, thin and wrinkled skin that appeared prematurely aged...
January 31, 2019: BMC Dermatology
https://read.qxmd.com/read/30674299/mucous-membrane-pemphigoid-associated-paronychia-with-onychomadesis
#2
Salim Alkeraye, Sarah F Alsukait
BACKGROUND: Mucous membrane pemphigoid (MMP) is an autoimmune blistering disease that is notoriously difficult to treat. Nail involvement in MMP is rare. CASE PRESENTATION: We report on a 58 years old man with severe MMP who presented with onychomadesis. CONCLUSION: To our knowledge, mucous membrane pemphigoid associated paronychia and onychomadesis have not been reported before. We believe it is important for dermatologists to be aware of this entity...
January 23, 2019: BMC Dermatology
https://read.qxmd.com/read/30670022/proderm-technology-a-water-based-lipid-delivery-system-for-dermatitis-that-penetrates-viable-epidermis-and-has-antibacterial-effects
#3
Alexandra Charruyer, Mats Silvander, Melinda Caputo-Janhager, Isabelle Raymond, Ruby Ghadially
BACKGROUND: A defective skin barrier and bacterial colonization are two important factors in maintenance and progression of atopic dermatitis and chronic allergic/irritant hand dermatitis. A water-based lipid delivery system containing physiologic lipids was previously shown to be a useful adjunct in the treatment of hand dermatitis. We tested the ability of this formulation to penetrate into the viable epidermis and in addition assessed its antibacterial properties. METHODS: Epidermal penetration of the product was assessed by fluorescence microscopy...
January 22, 2019: BMC Dermatology
https://read.qxmd.com/read/30611259/differences-in-microrna-expression-between-melanoma-and-healthy-adjacent-skin
#4
Mariya Aksenenko, Nadezhda Palkina, Anna Komina, Liubov Tashireva, Tatiana Ruksha
BACKGROUND: The tumor microenvironment is composed of cancer-associated fibroblasts, tumor-associated macrophages, endothelial cells, immune cells, signaling molecules and extracellular matrix structures, which closelycommunicate with the tumor via multiple mechanisms. MicroRNAs are paracrine regulators that provide a direct interaction between the microenvironment and cancer cells. In the presentstudy, we aimed to identify the microRNA expression profile in melanoma compared with thatin healthy adjacent skin, with a further assessment of altered microRNA signaling pathways and target genes...
January 5, 2019: BMC Dermatology
https://read.qxmd.com/read/30541516/interdisciplinary-and-multiprofessional-outpatient-secondary-individual-prevention-of-work-related-skin-diseases-in-the-metalworking-industry-1-year-follow-up-of-a-patient-cohort
#5
Annika Wilke, Günther Gediga, Andreas Goergens, Andreas Hansen, Anja Hübner, Swen Malte John, Kathrin Nordheider, Marc Rocholl, Sabine Weddeling, Britta Wulfhorst, Dorothée Nashan
BACKGROUND: In Germany, work-related skin diseases are predominant within the spectrum of reported occupational diseases. Metal workers are among the high-risk professions. Offering effective prevention programs to affected patients is of utmost importance to avoid deterioration of the disease and job loss. We conducted a 1-year follow-up in patients who participated in a multidisciplinary, complex outpatient prevention program representing a standard procedure of patient care by the respective statutory accident insurance...
December 12, 2018: BMC Dermatology
https://read.qxmd.com/read/30509232/assessing-skin-disease-and-associated-health-related-quality-of-life-in-a-rural-lao-community
#6
C I Wootton, S Bell, A Philavanh, K Phommachack, M Soukavong, S Kidoikhammouan, S L Walker, M Mayxay
BACKGROUND: Skin diseases are common and often have an impact on an individual's health-related quality of life. In rural communities where access to healthcare may be limited and individuals rely on farming for food and income, the impact of skin diseases may be greater. The objectives for this study were to perform an assessment of skin disease prevalence in a rural village in Laos and assess the associated impact of any skin disease found using the Dermatology Life Quality Index (DLQI)...
December 4, 2018: BMC Dermatology
https://read.qxmd.com/read/30400871/exploratory-study-of-the-reproducibility-of-the-score-for-intrinsic-and-extrinsic-skin-aging-scinexa-scale-in-ruta-escondida-de-la-mitad-del-mundo-ecuador-2017
#7
Martha Fors, Santiago Palacios, Kirsten Falcon, Karla Ventimilla, Lilia Simbaña, Carlos Lagos, Nélida Lasso, Carlos Navas
BACKGROUND: Few studies have been published related to the analysis of different skin aging parameters for whole-body skin using the SCINEXA scale for skin damage. The aim of this study was to evaluate the reproducibility of the SCINEXA scale (SCore for INtrinsic and EXtrinsic skin Aging) in South-Americans non-Caucasian population of a region of Ecuador. METHODS: Exploratory observational study. Thirty subjects of both genders, over 40 years old and living in a rural area with particular characteristics regarding sun exposure were included...
November 6, 2018: BMC Dermatology
https://read.qxmd.com/read/30373584/cost-and-effectiveness-of-prescribing-emollient-therapy-for-atopic-eczema-in-uk-primary-care-in-children-and-adults-a-large-retrospective-analysis-of-the-clinical-practice-research-datalink
#8
George Moncrieff, Annie Lied-Lied, Gill Nelson, Chantal E Holy, Rachel Weinstein, David Wei, Simon Rowe
BACKGROUND: The Clinical Practice Research Datalink (CPRD) was used to evaluate the overall costs to the National Health Service, including healthcare utilisation, of prescribing emollients in UK primary care for dry skin and atopic eczema (DS&E). METHODS: Primary care patients in the UK were identified using the CPRD and their records were interrogated for the 2 years following first diagnosis of DS&E. Data from patients with (n = 45,218) and without emollient prescriptions (n = 9780) were evaluated...
October 29, 2018: BMC Dermatology
https://read.qxmd.com/read/30359231/patient-reported-outcomes-in-urticarial-vasculitis-treated-with-omalizumab-case-report
#9
Ivan Cherrez-Ojeda, Emanuel Vanegas, Miguel Felix, Valeria L Mata, Annia Cherrez
BACKGROUND: Despite the current knowledge of UV, there is a lack of consensus among diagnostic criteria and management. In general, antihistamine therapy is regularly used for the symptomatic management of pruritus but does not control inflammation or alter the course of the disease. Monoclonal antibodies such as omalizumab (anti-IgE) have been proposed as a potential treatment for urticarial vasculitis. A few studies have reported the benefits of omalizumab in patient-reported outcome measures (PROMs)...
October 25, 2018: BMC Dermatology
https://read.qxmd.com/read/30134886/acne-in-lom%C3%A3-togo-clinical-aspects-and-quality-of-life-of-patients
#10
Bayaki Saka, Abla Séfako Akakpo, Julienne Noude Téclessou, Abas Mouhari-Toure, Garba Mahamadou, Piham Gnossike, Waguéna Gnassingbé, Aurel Abilogoun-Chokki, Adjalamotom Tawelessi, Koussake Kombaté, Palokinam Pitché
BACKGROUND: Acne is a chronic inflammatory condition affecting the pilosebaceous follicle that mainly affects adolescents and young adults. The aim of this study was to assess the quality of life (QOL) of patients with acne, and to determine the correlation between the QOL and the severity of acne, in Lomé (Togo). METHOD: From July 2017 to February 2018, we conducted a study in three dermatology departments of Lomé. The clinical evaluation of acne and assessment of the QOL were done using the ECLA (Echelle de Cotation des Lésions d'acné) and CADI (Cardiff Acne Disability Index) scores respectively...
August 22, 2018: BMC Dermatology
https://read.qxmd.com/read/30041646/expert-consensus-on-the-management-of-dermatophytosis-in-india-ectoderm-india
#11
Murlidhar Rajagopalan, Arun Inamadar, Asit Mittal, Autar K Miskeen, C R Srinivas, Kabir Sardana, Kiran Godse, Krina Patel, Madhu Rengasamy, Shivaprakash Rudramurthy, Sunil Dogra
BACKGROUND: Dermatophytosis management has become an important public health issue, with a large void in research in the area of disease pathophysiology and management. Current treatment recommendations appear to lose their relevance in the current clinical scenario. The objective of the current consensus was to provide an experience-driven approach regarding the diagnosis and management of tinea corporis, cruris and pedis. METHODS: Eleven experts in the field of clinical dermatology and mycology participated in the modified Delphi process consisting of two workshops and five rounds of questionnaires, elaborating definitions, diagnosis and management...
July 24, 2018: BMC Dermatology
https://read.qxmd.com/read/29996929/persistence-rates-and-medical-costs-of-biological-therapies-for-psoriasis-treatment-in-japan-a-real-world-data-study-using-a-claims-database
#12
Rosarin Sruamsiri, Kosuke Iwasaki, Wentao Tang, Jörg Mahlich
BACKGROUND: Biological therapies (BTs) including infliximab (IFX), adalimumab (ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment of psoriasis. Although the persistence rates and medical costs of BTs treatment have been investigated in multiple foreign studies in recent years, few such studies have been conducted in Japan and the differences between patients who adhered to treatment and those who did not have not been reported. This study is aimed at investigating the persistence rates and medical costs of BTs in the treatment of psoriasis in Japan, using the real-world data from a large-scale claims database...
July 11, 2018: BMC Dermatology
https://read.qxmd.com/read/29954363/real-world-health-outcomes-in-adults-with-moderate-to-severe-psoriasis-in-the-united-states-a-population-study-using-electronic-health-records-to-examine-patient-perceived-treatment-effectiveness-medication-use-and-healthcare-resource-utilization
#13
April W Armstrong, Shonda A Foster, Brian S Comer, Chen-Yen Lin, William Malatestinic, Russel Burge, Orin Goldblum
BACKGROUND: Little is known regarding real-world health outcomes data among US psoriasis patients, but electronic health records (EHR) that collect structured data at point-of-care may provide opportunities to investigate real-world health outcomes among psoriasis patients. Our objective was to investigate patient-perceived treatment effectiveness, patterns of medication use (duration, switching, and/or discontinuation), healthcare resource utilization, and medication costs using real-world data from psoriasis patients...
June 28, 2018: BMC Dermatology
https://read.qxmd.com/read/29415699/can-an-app-supporting-psoriasis-patients-improve-adherence-to-topical-treatment-a-single-blind-randomized-controlled-trial
#14
Mathias Tiedemann Svendsen, Flemming Andersen, Kirsten Hammond Andersen, Klaus Ejner Andersen
BACKGROUND: Topical corticosteroid or corticosteroid/calcipotriol preparations are recommended first-line topical treatments of psoriasis, but a main cause for the lack of efficacy of topical treatments is considered low rates of adherence to topical drugs. Patient support by the use of applications (apps) for smartphones is suggested to improve medical adherence. METHODS/DESIGN: Design: An investigator-initiated, single-center, single-blind, parallel-group, phase-4 clinical superiority randomized controlled trial (RCT)...
February 7, 2018: BMC Dermatology
https://read.qxmd.com/read/29415693/elucidating-mechanistic-insights-into-drug-action-for-atopic-dermatitis-a-systems-biology-approach
#15
Indhupriya Subramanian, Vivek K Singh, Abhay Jere
BACKGROUND: Topical Betamethasone (BM) and Pimecrolimus (PC) are widely used drugs in the treatment of atopic dermatitis (AD). Though the biomolecules and biological pathways affected by the drugs are known, the causal inter-relationships among these pathways in the context of skin is not available. We aim to derive this insight by using transcriptomic data of AD skin samples treated with BM and PC using systems biology approach. METHODS: Transcriptomic datasets of 10 AD patients treated with Betamethasone and Pimecrolimus were obtained from GEO datasets...
February 7, 2018: BMC Dermatology
https://read.qxmd.com/read/29352809/a-novel-plec-nonsense-homozygous-mutation-c-7159g-t-p-glu2387-causes-epidermolysis-bullosa-simplex-with-muscular-dystrophy-and-diffuse-alopecia-a-case-report
#16
Zoe Argyropoulou, Lu Liu, Linda Ozoemena, Claudia C Branco, Raquel Senra, Ângela Reis-Rego, Luisa Mota-Vieira
BACKGROUND: Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD; OMIM #226670) is an autosomal recessive disease, characterized mainly by skin blistering at birth or shortly thereafter, progressive muscle weakness, and rarely by alopecia. EBS-MD is caused by mutations in the PLEC gene (OMIM *601282), which encodes plectin, a structural protein expressed in several tissues, including epithelia and muscle. We describe a patient affected with EBS-MD and diffuse alopecia in which we identified a novel pathogenic mutation by PCR amplification of all coding exons and exon-intron boundaries of PLEC gene, followed by bidirectional Sanger sequencing...
January 20, 2018: BMC Dermatology
https://read.qxmd.com/read/29262820/a-case-report-of-erythroderma-in-a-patient-with-borderline-leprosy-on-reversal-reaction-a-result-of-the-exacerbated-reaction
#17
Denis Miyashiro, Ana Paula Vieira, Maria Angela Bianconcini Trindade, João Avancini, José Antonio Sanches, Gil Benard
BACKGROUND: Erythroderma is characterized by erythema and scaling affecting more than 90% of the body surface area. Inflammatory, neoplastic and, more rarely, infectious diseases may culminate with erythroderma. Diagnosis of the underlying disorder is therefore crucial to institute the appropriate therapy. Leprosy is a chronic infectious disease that is endemic in Brazil. Here we present an unusual case of leprosy and reversal reaction causing erythroderma, and we discuss the underlying immunological mechanisms which could contribute to the generalized skin inflammation...
December 20, 2017: BMC Dermatology
https://read.qxmd.com/read/29233122/composite-hemangioendothelioma-of-the-forehead-and-right-eye-a-case-report
#18
Ghasem Rahmatpour Rokni, Fatemeh Montazer, Mahnaz Sharifian, Mohamad Goldust
BACKGROUND: Hemangioendothelioma includes several types of vascular neoplasms , as well as both benign and malignant growth. CASE PRESENTATION: This study evaluated a case of a 78-year-old female diagnosed with composite hemangioendothelioma (CHE). This patient had an 18-month history of painless inflammatory lesions and erythema on the left forehead and right upper eyelid. The clinical and pathologic characteristics of the CHE were evaluated in the present study...
December 12, 2017: BMC Dermatology
https://read.qxmd.com/read/29183309/assessment-of-the-effects-of-skin-microneedling-as-adjuvant-therapy-for-facial-melasma-a-pilot-study
#19
Emerson V A Lima, Mariana Modesto D A Lima, Mauricio Pedreira Paixão, Hélio Amante Miot
BACKGROUND: Melasma is a common chronic and relapsing acquired dyschromia. Skin microneedling was reported resulting sustained long-term improvement of recalcitrant melasma, however, the exact mechanism that promotes this skin lightening is not known. This study aimed to investigate clinical and histologic alterations promoted by skin microneedling in facial melasma. METHODS: Open pilot trial including six women with facial refractory melasma submitted to two sessions of microneedling (1...
November 28, 2017: BMC Dermatology
https://read.qxmd.com/read/29166932/bap1-case-report-and-insight-into-a-novel-tumor-suppressor
#20
Kanad Ghosh, Badri Modi, William D James, Brian C Capell
BACKGROUND: BRCA1-Associated-Protein 1 (BAP1) is a dynamic tumor suppressor which, when mutated, has been associated with an increased risk of uveal melanoma, cutaneous melanoma, mesothelioma, and several other cancers. Germline BAP1 mutations have been extensively studied, where they have been found to cause hereditary cancer susceptibility. However, their sporadic counterparts, tumors that display a loss of BAP1 expression due to somatically arising mutations in the BAP1 gene, remain a poorly described entity...
November 22, 2017: BMC Dermatology
journal
journal
36181
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"